A new series of novel 2-morpholino-N-(4,6-diarylpyrimidin-2-yl)acetamides 34-42 is synthesized by the condensation of 2-chloro-N-(4,6-diarylpyrimidin-2-yl)acetamides 25-33 with morpholine in the presence of anhydrous potassium carbonate. The synthesized compounds have been characterized by melting point, elemental analysis, MS, FT-IR, one-dimensional NMR ( 1 H & 13 C) spectroscopic data.
INTRODUCTION
Pyrimidines being an integral part of nucleic acids and many chemotherapeutic agents display a wide range of pharmacological activities as bactericide, 1 fungicide, 2 phosphodiesterase inhibitor, 3 viricide, 4 and leishmancide. 5 Pyrimidines are the basic nucleus in nucleic acids and have been associated with a number of biological activities. 6 Substituted aminopyrimidine nuclei are common in marketed drugs such as anti-atherosclerotic aronixil, anti-histaminic thonzylamine, anti-anxielytic buspirone, anti-psoriatic enazadrem, and other medicinally relevant compounds. 7 Many pyrimidine derivatives have been found to be active against different forms of cancer. 8 Various method of synthesis and reactions of aminopyrimidines are reported. [9] [10] [11] Amides are well known for their therapeutic values. 12 The chemistry of chloro acetyl group has received significant attention through the years resulting in substantial advances both in the synthetic and medicinal aspects. N-Benzyl-β-chloropropionamide is a well-proven anticonvulsant agent 13 and is marketed under the trade name Hibicon and Hydrane. Chloroacetyl derivatives of some amines were found to exert diverse biological properties such as antiepileptic, 14 antiplasmodic, 15 antitumour, anti-MDR, 16 antimicrobial, 17 herbicidal, 18 mild stimulant and depressant activities. 19 Antibiotics like penicillins and cephalosporins have amide group. Novel bioactive natural compounds 20 are synthesized by the conversion of ketones into amides, since amide group is an important pharmacophores. Many N-fuctionalized morpholines have found to posses diverse pharmacological activites. They are reported to exert a number of important physiological activities such as antidiabetic, 21, 22 antiemetic, 23, 24 platelet aggregation inhibitors and antihyperlipo-proteinemics, 21 bronchodilators and growth stimulants 25 and antidepressants. 26 These were also used in the HN O Scheme 1. Synthetic route for the formation of 2-morpholino-N-(4,6-diarylpyrimidin-2-yl)acetamides treatment of inflammatory diseases, pain, migraine and asthma. 24 Recently, we exploited the synthesis of some novel structurally diverse heterocyclic compounds comprising pyrimidine nucleus such as 3,4-dihydropyrimidin-2(1H)-ones 27 and -thiones and 2-phenyl-3-(4,6-diarylpyrimidin-2-yl)thiazolidin-4-ones, 28 morpholine nucleus namely (E)-1-4-morpholinophenyl)-3-aryl-prop-2-en-1-ones 29 and amide moiety such as 2,7-diaryl- [1, 4] -diazepan-5-ones. 30 In the interest of above, we planned to synthesize a target molecule, 2-morpholino-N-(4,6-diarylpyrimidin-2-yl)acetamides which unite biolabile 4,6-diarylpyrimidin-2-amines, chloroacetyl chloride and morpholine moieties together to furnish a new series of compounds.
RESULTS AND DUSCUSSION
A four-step synthetic route furnished the target compounds 2-morpholino-N-(4,6-diarylpyrimidin-2-yl)acetamides 34-42 in good yields. A general schematic representation is given in Scheme 1. The Claisen-Schmidt 31 condensation of equimolar quantities of appropriate acetophenone and appropriate benzaldehyde in the presence of sodium hydroxide gives Table 1 .
The following nine compounds 34-42 are synthesized from the corresponding 2-chloro-N-(4,6-diarylpyrimidin-2-yl)acetamides 25-33: ❖ N-(4,6-bis(4-fluorophenyl)pyrimidin-2-yl)2-morpholinoacetamide 40 ❖ N-(4-(4-fluorophenyl)-6-(4-methylphenyl)pyrimidin-2-yl)2-morpholinoacetamide 41 ❖ N-(4-(4-methylphenyl)-6-(4-fluorophenyl)pyrimidin-
2-yl)2-morpholinoacetamide 42
The structures of all the newly synthesized compounds are characterized by m.p.'s, elemental analysis, FT-IR, MS, onedimensional NMR ( 1 H and 13 C) spectra.
FT-IR spectrum of 2-morpholino-N-(4,6-diphenylpyrimidin-2-yl)acetamide 34 shows characteristic absorption frequency (Table 2) Table 3 and 4 respectively.
CONCLUSION
In conclusion, we have synthesized a series of 2-morpholino-N-(4,6-diarylpyrimidin-2-yl)acetamides 34-42 by a four step synthetic route in good yields and characterized by their physical and analytical data. The target molecules 34-42 have pharmacophoric group such as amide besides the presence of biologically active morpholine and pyrimidine nuclei. The biological screening studies are under progress to evaluate the antibacterial, antifungal, antioxidant and anticancer potencies of the newly synthesized of 2-morpholino-N-(4,6-diarylpyrimidin-2-yl)acetamides 34-42.
EXPERIMENTAL
Thin layer chromatography (TLC) was carried out to monitor the course of the reaction and purity of the product. All the reported melting points were taken in open capillaries and were uncorrected. IR spectra were recorded in KBr (pellet forms) on a Thermo Nicolet-Avatar-330 FT-IR spectrophotometer and important absorption values (cm mol) and morpholine (0.005 mol) in dry toluene was refluxed for about 8 ~ 10 h. After completion of the reaction, potassium carbonate was removed by filtration and excess of solvent was removed under reduced pressure. The obtained residues were purified by column chromatography using benzene and ethylacetate (1:1) mixture as eluent which afforded 2-morpholino-N-(4,6-diarylpyrimidin-2-yl)acetamides 34-42 in good yields.
